Blandishment
发表于 2025-3-21 16:11:33
书目名称Biologic Therapy of Leukemia影响因子(影响力)<br> http://impactfactor.cn/if/?ISSN=BK0187289<br><br> <br><br>书目名称Biologic Therapy of Leukemia影响因子(影响力)学科排名<br> http://impactfactor.cn/ifr/?ISSN=BK0187289<br><br> <br><br>书目名称Biologic Therapy of Leukemia网络公开度<br> http://impactfactor.cn/at/?ISSN=BK0187289<br><br> <br><br>书目名称Biologic Therapy of Leukemia网络公开度学科排名<br> http://impactfactor.cn/atr/?ISSN=BK0187289<br><br> <br><br>书目名称Biologic Therapy of Leukemia被引频次<br> http://impactfactor.cn/tc/?ISSN=BK0187289<br><br> <br><br>书目名称Biologic Therapy of Leukemia被引频次学科排名<br> http://impactfactor.cn/tcr/?ISSN=BK0187289<br><br> <br><br>书目名称Biologic Therapy of Leukemia年度引用<br> http://impactfactor.cn/ii/?ISSN=BK0187289<br><br> <br><br>书目名称Biologic Therapy of Leukemia年度引用学科排名<br> http://impactfactor.cn/iir/?ISSN=BK0187289<br><br> <br><br>书目名称Biologic Therapy of Leukemia读者反馈<br> http://impactfactor.cn/5y/?ISSN=BK0187289<br><br> <br><br>书目名称Biologic Therapy of Leukemia读者反馈学科排名<br> http://impactfactor.cn/5yr/?ISSN=BK0187289<br><br> <br><br>
Thyroxine
发表于 2025-3-21 23:46:51
Radiolabeled Monoclonal Antibodies-mediated cytotoxicity (ADCC), in which an effector cell expressing an Fc receptor binds to a cell-bound MAb and is triggered to kill the target cell. Examples of antibodies with intrinsic immunologically mediated antitumor activity include the chimeric anti-CD20 antibody rituximab . and the humaniz
CLAN
发表于 2025-3-22 00:23:28
http://reply.papertrans.cn/19/1873/187289/187289_3.png
浮雕宝石
发表于 2025-3-22 07:33:16
http://reply.papertrans.cn/19/1873/187289/187289_4.png
Oligarchy
发表于 2025-3-22 12:39:12
http://reply.papertrans.cn/19/1873/187289/187289_5.png
Tartar
发表于 2025-3-22 13:21:34
http://reply.papertrans.cn/19/1873/187289/187289_6.png
Gudgeon
发表于 2025-3-22 18:17:06
http://reply.papertrans.cn/19/1873/187289/187289_7.png
gorgeous
发表于 2025-3-22 23:53:16
Franz J. Frei,Thomas Erb,Robert Sümpelmann in their eradication. The . Web site currently lists 596 clinical trials initiated since 1989, including 376 (63%) that are related to the treatment of malignancies, with 2389 patients enrolled in cancer-related gene therapy protocols .. A total of 46 (8%) of all gene therapy trials focus on the tr
leniency
发表于 2025-3-23 01:42:45
Human Leukemia-Derived Dendritic Cells as Tools for Therapy such as the recently developed tyrosine kinase inhibitor Imatinib Mesylate, may fail to control advanced forms of the target disease .. Additionally, for many human leukemias, no such well-defined genetic background is available at present. Accordingly, efforts to advance the therapy for these diseases must focus on other approaches.
fibroblast
发表于 2025-3-23 09:19:53
Interleukin-2 Treatment of Acute Leukemia(AML), 60–80% of patients will initially achieve complete remission (CR) but the majority of them will relapse .. Only 10%–30% of patients achieve prolonged leukemia-free survival .. In the case of acute lymphocytic leukemia (ALL), 60–65% of children can achieve long-term survival but only 10–30% of adults survive 5 yr free of recurrence ..